Correlation Between Sunshine Biopharma and Thayer Ventures

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sunshine Biopharma and Thayer Ventures at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sunshine Biopharma and Thayer Ventures into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sunshine Biopharma and Thayer Ventures Acquisition, you can compare the effects of market volatilities on Sunshine Biopharma and Thayer Ventures and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sunshine Biopharma with a short position of Thayer Ventures. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sunshine Biopharma and Thayer Ventures.

Diversification Opportunities for Sunshine Biopharma and Thayer Ventures

0.21
  Correlation Coefficient

Modest diversification

The 3 months correlation between Sunshine and Thayer is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Sunshine Biopharma and Thayer Ventures Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Thayer Ventures Acqu and Sunshine Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sunshine Biopharma are associated (or correlated) with Thayer Ventures. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Thayer Ventures Acqu has no effect on the direction of Sunshine Biopharma i.e., Sunshine Biopharma and Thayer Ventures go up and down completely randomly.

Pair Corralation between Sunshine Biopharma and Thayer Ventures

Given the investment horizon of 90 days Sunshine Biopharma is expected to under-perform the Thayer Ventures. But the stock apears to be less risky and, when comparing its historical volatility, Sunshine Biopharma is 2.21 times less risky than Thayer Ventures. The stock trades about -0.1 of its potential returns per unit of risk. The Thayer Ventures Acquisition is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  6.00  in Thayer Ventures Acquisition on August 28, 2024 and sell it today you would lose (4.96) from holding Thayer Ventures Acquisition or give up 82.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Sunshine Biopharma  vs.  Thayer Ventures Acquisition

 Performance 
       Timeline  
Sunshine Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sunshine Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's technical and fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Thayer Ventures Acqu 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Thayer Ventures Acquisition are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Thayer Ventures showed solid returns over the last few months and may actually be approaching a breakup point.

Sunshine Biopharma and Thayer Ventures Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sunshine Biopharma and Thayer Ventures

The main advantage of trading using opposite Sunshine Biopharma and Thayer Ventures positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sunshine Biopharma position performs unexpectedly, Thayer Ventures can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Thayer Ventures will offset losses from the drop in Thayer Ventures' long position.
The idea behind Sunshine Biopharma and Thayer Ventures Acquisition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk